Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 12:48PM ET - U.S. Markets close in 3 hours and 12 minutes. Dow  0.26% Nasdaq  0.61%

Alnylam Pharmaceuticals, Inc. (ALNY)

At 12:33PM ET: 16.55   0.23 (1.37%)

MORE ON ALNY

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Company Events Get Company Events for:
UPCOMING EVENTS   Date Event Reminder No Upcoming Events RECENT EVENTS   Date Event 24-Nov-09 Alnylam Pharma downgraded by Roth Capital 4-Nov-09 Alnylam Pharmaceuticals Earnings Call scheduled for 4:30 pm ET today 4-Nov-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a 4-Nov-09 Earnings announcement 25-Aug-09 Price hit new 52-week high ($24.75) 21-Aug-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 7-Aug-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 6-Aug-09 Alnylam Pharmaceuticals Earnings Call scheduled for 4:30 pm ET today 6-Aug-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 27-Jul-09 Price hit new 52-week high ($23.44) 17-Jul-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement 2-Jul-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement 8-May-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 7-May-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 5-May-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement 9-Mar-09 Price hit new 52-week low ($14.82) 4-Mar-09 Price hit new 52-week low ($15.85) 3-Mar-09 Price hit new 52-week low ($15.87) 2-Mar-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report 24-Feb-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 6-Feb-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 15-Jan-09 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement 15-Dec-08 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 7-Nov-08 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 5-Nov-08 ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Add to Portfolio     Set Alert     Email to a Friend Get Company Events for Another Symbol: Symbol Lookup • Splits Calendar • Mergers & Acquisitions Calendar